Provided by Goodwin
Goodwin’s Antitrust & Competition team has unparalleled expertise in handling the full range of antitrust matters for our clients, from merger clearance to complex litigation. In parallel with the firm’s focus on the technology, life science and private equity industries, our antitrust lawyers bring decades of experience in advising clients in these industries on their most complex antitrust matters.
Merger Clearance
Our success is measured by our key motivation: keeping our clients out of the antitrust news and securing clearance of their transactions. Having advised on more than 2,500 transactions, Goodwin’s Antitrust & Competition lawyers routinely counsel clients from the largest Fortune 500 companies to emerging growth companies. In many industry verticals with heightened antitrust scrutiny, we guide more transactions through the agencies than any other firm.
Litigation & Enforcement
With a roster of former federal prosecutors, business counselors and seasoned trial lawyers, our Antitrust & Competition team handles the gamut of antitrust litigation matters from criminal enforcement to complex civil litigation
Provided by Chambers
Goodwin has a sophisticated offering, boasting strong ties to the pharmaceutical and life sciences sectors. Regularly sought out for assistance on complex litigation as well as in government investigations. Also able to leverage a strong national and global bench.
Provided by Goodwin
Goodwin represented Teva Pharmaceuticals in an antitrust lawsuit alleging it and Gilead had unlawfully conspired to delay the sale of generic versions of the HIV treatments Truvada and Atripla when they settled related patent litigation in 2014.
Provided by Chambers
"The Goodwin team is making great strides in the pharmaceutical area."
"Goodwin's attorneys are always responsive."
"The Goodwin team is making great strides in the pharmaceutical area."
"Goodwin's attorneys are always responsive."
Provided by Chambers
Christopher Holding offers pharmaceutical clients accomplished representation in antitrust matters pertaining to product pricing. He is further able to advise on matters at the intersection of IP and antitrust.
Provided by Goodwin